Xeriant, Inc./ US98422N1037 /
24/05/2024 21:27:23 | Var. -0.0020 | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
0.0280USD | -6.67% | 99,285 Fatturato: 2,890.3700 |
-Quantità in denaro: - | -Quantità in lettera: - | 0.0300 | 0.0280 |
GlobeNewswire
07:00
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
GlobeNewswire
06:00
For startups changing the world, an AI company called Bizzline brings the power to tell their own st...
GlobeNewswire
05:21
Flash News: OKX Wallet Announces Near Protocol Integration, Supports Over 95 Blockchains
Newsfile Corp
04:12
InsFollowPro Acquires Statigr.am: A New Chapter in Social Media Analytics and Growth
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spr...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Int...
GlobeNewswire
03:00
CAMBIUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Agai...
GlobeNewswire
03:00
VERRICA ALERT: Bragar Eagel & Squire, P.C. is Investigating Verrica Pharmaceuticals, Inc. on Behalf ...
GlobeNewswire
02:12
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Blueprint Medi...
GlobeNewswire
01:47
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avangrid, Inc....